User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.

Primary tabs

Delpierrre, Ghislain [UCL] Vertommen, Didier [UCL] Communi, David Rider, Mark H. [UCL] Van Schaftingen, Emile [UCL]

Fructosamine-3-kinase (FN3K) phosphorylates fructosamine residues, leading to their destabilization and their shedding from protein. Support for the occurrence of this deglycation mechanism in intact cells has been obtained by showing that hemoglobin is significantly more glycated when human erythrocytes are incubated with an elevated glucose concentration in the presence of 1-deoxy-1-morpholinofructose (DMF), a cell-permeable inhibitor of FN3K, than in its absence. The aim of this work was to identify the fructosamine residues on hemoglobin that are removed as a result of the action of FN3K in intact erythrocytes. Highly glycated hemoglobin derived from intact human erythrocytes incubated for 48 h with 200 mm glucose and DMF was incubated in vitro with FN3K and [gamma-(32)P]ATP. After reduction of fructosamine 3-phosphates with borohydride, the protein was digested with trypsin. Peptides were separated by reversed-phase high-performance liquid chromatography, and the radioactive peaks were analyzed by mass spectrometry. Nine different modified residues were identified. These were Lys-alpha-16, Lys-alpha-61, Lys-alpha-139, Val-beta-1, Lys-beta-17, Lys-beta-59, Lys-beta-66, Lys-beta-132, and Lys-beta-144. Some (e.g. Lys-alpha-139) were readily phosphorylated to a maximal extent by FN3K in vitro whereas others (e.g. Val-beta-1) were slowly and only very partially phosphorylated. The radiolabeled peptides containing reduced fructosamine 3-phosphates bound to Lys-alpha-16, Lys-alpha-139, and Lys-beta-17 were much less abundant if the hemoglobin substrate used for the in vitro phosphorylation with FN3K and [gamma-(32)P]ATP came from erythrocytes incubated with an elevated glucose concentration in the absence of DMF, indicating that these lysine residues had been substantially deglycated in intact cells when FN3K action was unrefrained. Other residues (e.g. Val-beta-1, Lys-alpha-61) seemed to be insignificantly deglycated in intact cells.

  1. DELPIERRE Ghislain, COLLARD François, FORTPIED Juliette, VAN SCHAFTINGEN Emile, Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes, 10.1042/bj20020325
  2. Moskovitz J., Weissbach H., Brot N., Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins., 10.1073/pnas.93.5.2095
  3. J. Biol. Chem., 255, 3120 (1980)
  4. Mossine Valeri V., Glinsky Gennadi V., Feather Milton S., The preparation and characterization of some Amadori compounds (1-amino-1-deoxy-d-fructose derivatives) derived from a series of aliphatic ω-amino acids, 10.1016/0008-6215(94)84183-7
  5. J. Biol. Chem., 181, 149 (1949)
  6. Folk J.E., The influence of the lysine-glucose reaction on enzymatic digestion, 10.1016/0003-9861(56)90236-3
  7. Zhang Xinyi, Medzihradszky Katalin F, Cunningham John, Lee Phillip D.K, Rognerud Cheryl L, Ou Ching-Nan, Harmatz Paul, Witkowska H.Ewa, Characterization of glycated hemoglobin in diabetic patients: usefulness of electrospray mass spectrometry in monitoring the extent and distribution of glycation, 10.1016/s0378-4347(01)00196-7
  8. Dumoulin Antoine, Manning Lois R., Jenkins W. Terry, Winslow Robert M., Manning James M., Exchange of Subunit Interfaces between Recombinant Adult and Fetal Hemoglobins : EVIDENCE FOR A FUNCTIONAL INTER-RELATIONSHIP AMONG REGIONS OF THE TETRAMER, 10.1074/jbc.272.50.31326
  9. J. Biol. Chem., 264, 12344 (1989)
  10. NADOLNY Garsten, KEMPF Ingrid, ZUNDEL Georg, Specific Interactions of the Allosteric Effector 2,3-Bisphosphoglycerate with Human Hemoglobin - A Difference FTIR Study, 10.1515/bchm3.1993.374.1-6.403
  11. Costa R, The eukaryotic nucleotide excision repair pathway, 10.1016/j.biochi.2003.10.017
  12. Fortini P, The base excision repair: mechanisms and its relevance for cancer susceptibility, 10.1016/j.biochi.2003.11.003
  13. J. Biol. Chem., 264, 20131 (1989)
  14. Paoli Massimo, Liddington Robert, Tame Jeremy, Wilkinson Anthony, Dodson Guy, Crystal Structure of T State Haemoglobin with Oxygen Bound At All Four Haems, 10.1006/jmbi.1996.0124
  15. Kim E., Lowenson J. D., MacLaren D. C., Clarke S., Young S. G., Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice, 10.1073/pnas.94.12.6132
  16. Moskovitz J., Bar-Noy S., Williams W. M., Requena J., Berlett B. S., Stadtman E. R., Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals, 10.1073/pnas.231472998
  17. Diabetes, 40, 405 (1991)
  18. Lab. Investig., 70, 138 (1994)
  19. Brownlee Michael, Biochemistry and molecular cell biology of diabetic complications, 10.1038/414813a
  20. Delpierre G., Rider M. H., Collard F., Stroobant V., Vanstapel F., Santos H., Van Schaftingen E., Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase, 10.2337/diabetes.49.10.1627
  21. Szwergold B. S., Howell S., Beisswenger P. J., Human Fructosamine-3-Kinase: Purification, Sequencing, Substrate Specificity, and Evidence of Activity In Vivo, 10.2337/diabetes.50.9.2139
Bibliographic reference Delpierrre, Ghislain ; Vertommen, Didier ; Communi, David ; Rider, Mark H. ; Van Schaftingen, Emile. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.. In: The Journal of biological chemistry, Vol. 279, no. 26, p. 27613-20 (2004)
Permanent URL http://hdl.handle.net/2078.1/21974